It is a time of transition in the area of biomarkers. Confusion is rampant,
progress immense and the challenges invigorating. Better diagnosis is poss
ible if we progress in a rational way and avoid the chaos so often characte
ristic of transitions by relying on the science of the discipline to keep u
s on track. (C) 1999 Elsevier Science BN. All rights reserved.